ARTELO BIOSCIENCES INC
For the period ended Dec 31, 2023. Filed Mar 25, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 25, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
| ARTELO BIOSCIENCES, INC. | ||
| Dated: March 25, 2024 | By: | /s/ Gregory D. Gorgas |
|---|---|---|
| Gregory D. Gorgas | ||
| President, Chief Executive Officer, | ||
| Chief Financial Officer, Treasurer and Director | ||
| (Principal Executive Officer, | ||
| Principal Financial Officer andPrincipal Accounting Officer) | ||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Gregory D. Gorgas, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitutes, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Dated: March 25, 2024 | /s/ Gregory D. Gorgas |
|---|---|
| Gregory D. Gorgas | |
| President, Chief Executive Officer, | |
| Chief Financial Officer, Treasurer and Director | |
| (Principal Executive Officer, | |
| Principal Financial Officer andPrincipal Accounting Officer) | |
| Dated: March 25, 2024 | /s/ Connie Matsui |
| Connie Matsui | |
| Director | |
| Dated: March 25, 2024 | /s/ Steven Kelly |
| Steven Kelly | |
| Director | |
| Dated: March 25, 2024 | /s/ Douglas Blayney |
| Douglas Blayney | |
| Director | |
| Dated: March 25, 2024 | /s/ R. Martin Emanuele |
| R. Martin Emanuele | |
| Director | |
| Dated: March 25, 2024 | /s/ Greg Reyes |
| Greg Reyes | |
| Director | |
| Dated: March 25, 2024 | /s/ Tamara A. (Seymour) Favorito |
| Tamara A. (Seymour) Favorito | |
| Director |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.